Last Orders: What you might have missed on the ASX today
Link copied to
ASX small caps saw another decline today, albeit with a more modest fall than yesterday.
The ASX Small Ordinaries index of 200 small-cap companies wrapped up the day down 0.35 per cent to 3,073.5
The ASX200 dropped as well – by 0.27 per cent to 6,679.1. Healthcare and materials were the key laggards while the financials sector was in the green.
The Emerging Companies index of nano-cap companies fell 0.44 per cent to 1,996.8.
Energy minnow Gas2Grid (ASX:GGX) climbed on a positive development in a legal fight with the French government. The company has been fighting a French government knock back renewal of its exploration permit for several years.
Today Gas2Grid advised shareholders it had not submitted a defence to a company’s $54 million claim for compensation.
Drug maker Acrux (ASX:ACR) announced the FDA had approved its generic testosterone topical solution. This means it can now manufacture and market it in the US.
Recently listed fintech lender Plenti Group (ASX:PLT) released a financial update in which it revealed the December quarter had been a record for the company.
Large cap burns treatment stock PolyNovo (ASX:PNV) also gave a trading update that left shareholders less than impressed. The company said sales had been slower than expected in October and November.
Keybridge submitted to the Takeovers Panel arguing there were “clear unacceptable circumstances” that should stop the process. It accused Webcentral of not disclosing a success fee payable to its financial adviser and argued that if it had shareholders would’ve made a different decision on the takeover.